Mark Verratti
Corporate Officer/Principal at MYRIAD GENETICS, INC.
Net worth: 5 M $ as of 29/04/2024
Profile
Mark Steven Verratti is currently the Managing Director at Myriad Genetics GmbH and the Chief Commercial Officer & President-Mental Health at Myriad Genetics, Inc. He previously worked as the Vice President-Sales at LivaNova USA, Inc. from 2005 to 2012 and as the SVP, Chief Sales & Business Development Officer at Assurex Health, Inc. Mr. Verratti completed his undergraduate degree at The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MYRIAD GENETICS, INC.
0.33% | 13/04/2024 | 298,715 ( 0.33% ) | 5 M $ | 29/04/2024 |
Mark Verratti active positions
| Companies | Position | Start |
|---|---|---|
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | 31/07/2017 |
Myriad Genetics GmbH
 Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Myriad Genetics GmbH provides clinical diagnostic test services. It specializes in generic testing and disease diagnostic services. The company is headquartered in Zurich, Switzerland. | Chief Executive Officer | - |
Former positions of Mark Verratti
| Companies | Position | End |
|---|---|---|
Assurex Health, Inc.
 Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | President | - |
| CYBERONICS, INC. | Sales & Marketing | - |
Training of Mark Verratti
| The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Myriad Genetics GmbH provides clinical diagnostic test services. It specializes in generic testing and disease diagnostic services. The company is headquartered in Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Mark Verratti
